Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Buschbeck

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Drugs in R&D|March 18, 2006
Strategies to overcome resistance to targeted protein kinase inhibitors in the treatment of cancerMarcus Buschbeck
Journal of Biomedicine & Biotechnology|January 29, 2011
Elongator: an ancestral complex driving transcription and migration through protein acetylationCatherine Creppe, Marcus Buschbeck
Cancers|March 3, 2018
Post-Translational Modifications of H2A Histone Variants and Their Role in CancerDavid Corujo, Marcus Buschbeck
The Journal of Biological Chemistry|November 19, 2004
The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttlingMarcus Buschbeck, Axel Ullrich
Molecular Cell|August 23, 2024
A FACT about macroH2A removal in immune gene activationOliver Meers, Marcus Buschbeck
Nature Reviews. Molecular Cell Biology|February 2, 2017
Variants of core histones and their roles in cell fate decisions, development and cancerMarcus Buschbeck, Sandra B Hake
Epigenetics|February 18, 2010
Approaching the molecular and physiological function of macroH2A variantsMarcus Buschbeck, Luciano Di Croce
Cellular and Molecular Life Sciences : CMLS|March 5, 2013
Macro domains as metabolite sensors on chromatinMelanija Posavec, Gyula Timinszky, Marcus Buschbeck
Cancer Letters|March 28, 2013
MacroH2A--an epigenetic regulator of cancerNeus Cantariño, Julien Douet, Marcus Buschbeck
The Journal of Biological Chemistry|December 9, 2003
Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1Miriam Gensler, Marcus Buschbeck, Axel Ullrich
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Drugs in R&D|March 18, 2006
Strategies to overcome resistance to targeted protein kinase inhibitors in the treatment of cancerMarcus Buschbeck
Journal of Biomedicine & Biotechnology|January 29, 2011
Elongator: an ancestral complex driving transcription and migration through protein acetylationCatherine Creppe, Marcus Buschbeck
Cancers|March 3, 2018
Post-Translational Modifications of H2A Histone Variants and Their Role in CancerDavid Corujo, Marcus Buschbeck
The Journal of Biological Chemistry|November 19, 2004
The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttlingMarcus Buschbeck, Axel Ullrich
Molecular Cell|August 23, 2024
A FACT about macroH2A removal in immune gene activationOliver Meers, Marcus Buschbeck
Nature Reviews. Molecular Cell Biology|February 2, 2017
Variants of core histones and their roles in cell fate decisions, development and cancerMarcus Buschbeck, Sandra B Hake
Epigenetics|February 18, 2010
Approaching the molecular and physiological function of macroH2A variantsMarcus Buschbeck, Luciano Di Croce
Cellular and Molecular Life Sciences : CMLS|March 5, 2013
Macro domains as metabolite sensors on chromatinMelanija Posavec, Gyula Timinszky, Marcus Buschbeck
Cancer Letters|March 28, 2013
MacroH2A--an epigenetic regulator of cancerNeus Cantariño, Julien Douet, Marcus Buschbeck
The Journal of Biological Chemistry|December 9, 2003
Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1Miriam Gensler, Marcus Buschbeck, Axel Ullrich
Pageof 8